NCT07237633 Evaluating the Feasibility of a Piezoelectric Smart Sensor as an Aid to Help Clinicians Screen for the Development of Pneumonia in an At-risk Population
| NCT ID | NCT07237633 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National University Hospital, Singapore |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-01-18 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-01-18 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This proposed research aims to evaluate the feasibility of the piezoelectric sensor as an aid to help clinicians screen for the development of pneumonia in an at-risk population.
Eligibility Criteria
Inclusion Criteria: 1. Aged 21 years and above 2. Acute stroke patients (i.e. MRI or CT brain findings consistent with diagnosis) or ESRF patients on HD who are mentally competent and cognitively fit to provide consent. Exclusion Criteria: 1. Individuals who are unable to give informed consent 2. Individuals with active dermatological conditions
Contact & Investigator
Hiang Ping CHAN, MBBS
PRINCIPAL INVESTIGATOR
National University Hospital, Singapore
Frequently Asked Questions
Who can join the NCT07237633 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07237633 currently recruiting?
Yes, NCT07237633 is actively recruiting participants. Contact the research team at hiang_ping_chan@nuhs.edu.sg for enrollment information.
Where is the NCT07237633 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT07237633 clinical trial?
NCT07237633 is sponsored by National University Hospital, Singapore. The principal investigator is Hiang Ping CHAN, MBBS at National University Hospital, Singapore. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.